ArticleAnnals of clinical and laboratory science2022

Development of Clinical-Grade Antibodies against Tumor-Specific Mutations to Target Neuroblastoma.

Stephanie C Pero et al.PubMed ↗Full text ↗

No numbers read from the abstract.